Výsledky vyhledávání - Geert‐Jan Creemers
- Zobrazuji výsledky 1 - 20 z 39
- Přejít na další stránku
-
1
Translocation of <i>BCR</i> to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, <i>BCR</i>‐positive patients with chronic myeloid leukemia Autor Anne Hagemeijer, Arjan Buijs, E.M.E. Smit, Bart Janssen, Geert‐Jan Creemers, D van der Plas, Gerard C. Grosveld
Vydáno 1993Artigo -
2
Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands Autor Laura M. Legué, Nienke Bernards, Sophie L. Gerritse, Thijs R. van Oudheusden, Ignace H. J. T. de Hingh, Geert-Jan Creemers, Albert J. ten Tije, V.E.P.P. Lemmens
Vydáno 2016Artigo -
3
Clinical management of women with metastatic breast cancer: a descriptive study according to age group Autor Klaartje Manders, Lonneke V. van de Poll‐Franse, Geert‐Jan Creemers, Gerard Vreugdenhil, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Rudi M. H. Roumen, Adri C. Voogd
Vydáno 2006Artigo -
4
Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature Autor Sabine Venderbosch, Johannes H.W. de Wilt, Steven Teerenstra, O. J. L. Loosveld, Aart van Bochove, Harm Sinnige, Geert-Jan Creemers, Margot Tesselaar, Linda Mol, Cornelis J.A. Punt, Miriam Koopman
Vydáno 2011Revisão -
5
A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan Autor Jessica M. van der Bol, Ron H.J. Mathijssen, Geert-Jan Creemers, André Planting, Walter J. Loos, Erik A.C. Wiemer, Lena E. Friberg, Jaap Verweij, Alex Sparreboom, Floris A. de Jong
Vydáno 2010Artigo -
6
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis Autor Maikel J. A. M. Bakens, Lydia G. van der Geest, Magreet van Putten, Hanneke W.M. van Laarhoven, Geert‐Jan Creemers, Marc G. Besselink, V.E.P.P. Lemmens, Ignace H. J. T. de Hingh
Vydáno 2016Artigo -
7
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study Autor Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marije Slingerland, Nadia Haj Mohammad, Judith de Vos‐Geelen, Laurens V. Beerepoot, Theo van Voorthuizen, Geert‐Jan Creemers, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven
Vydáno 2019Artigo -
8
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases Autor Koen P. Rovers, Checca Bakkers, Felice N. van Erning, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert A. Simkens, Geert-Jan Creemers, Patrick Hemmer, Cornelis J.A. Punt, V.E.P.P. Lemmens, Pieter J. Tanis, Ignace H. J. T. de Hingh
Vydáno 2020Artigo -
9
Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer:... Autor M. Bontenbal, Geert‐Jan Creemers, Hans J. Braun, A C de Boer, J Janssen, Rieneke B. Leys, Jan B. Ruit, S.H. Goey, P.C. van der Velden, L.G.M. Kerkhofs, Kristel L. Schothorst, Paul Schmitz, Hansje J. Bokma, Jaap Verweij, Caroline Seynaeve
Vydáno 2005Artigo -
10
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial Autor Inge Henselmans, Hanneke W.M. van Laarhoven, Hanneke C.J.M. de Haes, Meltem Tokat, Ellen G. Engelhardt, Pomme E. A. van Maarschalkerweerd, Marleen Kunneman, Petronella B. Ottevanger, Serge E. Dohmen, Geert-Jan Creemers, Dirkje W. Sommeijer, Filip De Vos, Ellen M.A. Smets
Vydáno 2018Artigo -
11
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial Autor Inge Henselmans, Hanneke W.M. van Laarhoven, Pomme E. A. van Maarschalkerweerd, Hanneke C.J.M. de Haes, Marcel G. W. Dijkgraaf, Dirkje W. Sommeijer, Petronella B. Ottevanger, Helle‐Brit Fiebrich, Serge E. Dohmen, Geert-Jan Creemers, Filip De Vos, Ellen M.A. Smets
Vydáno 2019Artigo -
12
Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for <b> <i>UGT1A1*28</i> </b> Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study Autor Floris A. de Jong, Diederik F.S. Kehrer, Ron H.J. Mathijssen, Geert‐Jan Creemers, Peter de Bruijn, Ron H. N. van Schaik, André Planting, Ate van der Gaast, Ferry A.L.M. Eskens, J Janssen, Jan B. Ruit, Jaap Verweij, Alex Sparreboom, Maja J.A. de Jonge
Vydáno 2006Artigo -
13
Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progre... Autor Paul Hamberg, Monique M.E.M. Bos, Hans J. Braun, Jacqueline M. Stouthard, Gert A. van Deijk, Frans Erdkamp, Iris N. van der Stelt-Frissen, M. Bontenbal, Geert-Jan Creemers, Johanneke E.A. Portielje, Hans Pruijt, O. J. L. Loosveld, Willem M. Smit, E.W. Muller, Paul Schmitz, Caroline Seynaeve, Jan G.M. Klijn
Vydáno 2011Artigo -
14
Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients Autor Sophie A. Kurk, Petra H.M. Peeters, Rebecca K. Stellato, Bram Dorresteijn, Pim de Jong, Marion Jourdan, Geert‐Jan Creemers, Frans Erdkamp, Felix de Jongh, Peter A. M. Kint, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J.A. Punt, Miriam Koopman, Anne M. May
Vydáno 2019Artigo -
15
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies Autor Niels A.D. Guchelaar, Bo Jan Noordman, Stijn L.W. Koolen, Bianca Mostert, Eva V. E. Madsen, Jacobus W. A. Burger, Alexandra R. M. Brandt‐Kerkhof, Geert-Jan Creemers, Ignace H. J. T. de Hingh, Misha Luyer, Sander Bins, Esther van Meerten, Sjoerd M. Lagarde, Cornelis Verhoef, Bas P. L. Wijnhoven, Ron H.J. Mathijssen
Vydáno 2023Revisão -
16
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients Autor Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert-Jan Creemers, Birgit Deiman, Jesse J. Swen, Saskia Houterman, Stijn L.W. Koolen, Sander Bins, Anna M.J. Thijs, Marjan Laven, Anke M. Hövels, Saskia Luelmo, Danny Houtsma, Katerina Shulman, Howard L. McLeod, Ron H. N. van Schaik, Henk‐Jan Guchelaar, Ron H.J. Mathijssen, Hans Gelderblom, Maarten J. Deenen
Vydáno 2022Artigo -
17
Experiences of patients with metastatic colorectal cancer participating in a supervised exercise intervention during chemotherapy Autor Calvin G. Brouwer, Marieke R. ten Tusscher, Bente M. de Roos, Elske C. Gootjes, Tineke E. Buffart, Kathelijn S. Versteeg, Isa H. Mast, Mirte Mayke Streppel, Inge M. Werter, Anne M. May, Henk M.W. Verheul, Laurien M. Buffart, Jeanine Roodhart, Miriam L. Wumkes, Dirkje W. Sommeijer, Geert-Jan Creemers, Hans‐Martin Otten, Annette van Zweeden, Aart Beeker, Johan J. B. Janssen, Karen Bolhuis
Vydáno 2025Artigo -
18
Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis Autor Jonathan E. Knikman, Tycho A. Wilting, Marta López‐Yurda, Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, Didier Meulendijks, Peter Nieboer, Helga Droogendijk, Geert-Jan Creemers, Caroline Mandigers, Alexander L.T. Imholz, Ron H.J. Mathijssen, Johanneke E.A. Portielje, Liselot Valkenburg‐van Iersel, Annelie Vulink, Marlene H.W. van der Poel, Arnold Baars, Jesse J. Swen, Hans Gelderblom, Jan H.M. Schellens, Jos H. Beijnen, Henk‐Jan Guchelaar, Annemieke Cats
Vydáno 2023Artigo -
19
Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease Autor Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt, Chantal Rieux, Jacques Bosq, Françoise Berger, T. Girinsky, Pauline Brice, Mars B. van’t Veer, Jan Walewski, P Lederlin, Umberto Tirelli, Patrice Carde, Éric Van Den Neste, Emmanuel Gyan, M. Monconduit, Marine Diviné, John Raemaekers, Gilles Salles, Evert M. Noordijk, Geert-Jan Creemers, Jean Gabarre, Anton Hagenbeek, Oumédaly Reman, Michel Blanc, José Thomas, Brigitte Vié, Hanneke C. Kluin‐Nelemans, Fernando Viseu, Joke W. Baars, Philip Poortmans, Pieternella J. Lugtenburg, C. Carrié, J. Jaubert, M. Henry‐Amar
Vydáno 2007Artigo -
20
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophagea... Autor Charlotte I. Stroes, Sandor Schokker, Aafke Creemers, Remco J. Molenaar, Maarten C.C.M. Hulshof, Stephanie O. van der Woude, Roel J. Bennink, Ron A. A. Mathôt, Kausilia K. Krishnadath, Cornelis J.A. Punt, Rob H.A. Verhoeven, Martijn G.H. van Oijen, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, Maurice J.C. van der Sangen, Laurens V. Beerepoot, Joos Heisterkamp, Maartje Los, Marije Slingerland, Annemieke Cats, Geke A.P. Hospers, Maarten F. Bijlsma, Mark I. van Berge Henegouwen, Sybren L. Meijer, Hanneke W.M. van Laarhoven
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Cancer
Oncology
Chemotherapy
Surgery
Colorectal cancer
Breast cancer
Randomized controlled trial
Biology
Gastroenterology
Confidence interval
Gene
Hazard ratio
Nursing
Ovarian cancer
Pharmacology
Radiation therapy
Adjuvant
Capecitabine
Chemoradiotherapy
Genetics
Pancreatic cancer
Proportional hazards model
Adenocarcinoma
Adjuvant chemotherapy
Cytoreductive surgery
Disease
Family medicine
Genotype